How to Demonstrate the Impact of Dapagliflozin on Improving Hyperuricemia in Patients with Chronic Kidney Disease

被引：0
|
作者：
Fujioka, Hayato [1 ]
Kataoka, Naoya [1 ]
Imamura, Teruhiko [1 ]
机构：
[1] Univ Toyama, Dept Internal Med 2, Toyama, Japan
来源：
INTERNAL MEDICINE | 2024年 / 63卷 / 15期
关键词：
uric acid; SGLT2; inhibitor; cardiovascular disease; heart failure;
D O I：
10.2169/internalmedicine.2725-23
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2227 / 2227
页数：1
相关论文
共 50 条
  • [41] Improving treatment for patients with chronic kidney disease
    Thomsen, Kendra
    Zuber, Kim
    Davis, Jane
    Thomas, Greg
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2016, 29 (11): : 46 - 52
  • [42] Hyperuricemia is associated with progression of chronic kidney disease in patients with reduced functioning kidney mass
    Galan, Isabel
    Goicoechea, Marian
    Quiroga, Borja
    Macias, Nicolas
    Santos, Alba
    Garcia de Vinuesa, Maria Soledad
    Verdalles, Ursula
    Cedeno, Santiago
    Verde, Eduardo
    Perez de Jose, Ana
    Garcia, Ana
    Luno, Jose
    NEFROLOGIA, 2018, 38 (01): : 73 - 78
  • [43] Effect of Dapagliflozin on Clinical Outcomes in Patients With Chronic Kidney Disease, With and Without Cardiovascular Disease
    McMurray, John J. V.
    Wheeler, David C.
    Stefansson, Bergur V.
    Jongs, Niels
    Postmus, Douwe
    Correa-Rotter, Ricardo
    Chertow, Glenn M.
    Greene, Tom
    Held, Claes
    Hou, Fan-Fan
    Mann, Johannes F. E.
    Rossing, Peter
    Sjostrom, C. David
    Toto, Roberto D.
    Langkilde, Anna Maria
    Heerspink, Hiddo J. L.
    CIRCULATION, 2021, 143 (05) : 438 - 448
  • [44] Outcomes associated with hyperuricemia in chronic kidney disease
    Ojie, Jude O.
    George, Sajid M.
    Sharma, Smriti
    Brijbassie, Alan
    Kalantar-Zadeh, Kamyar
    Kovesdy, Csaba P.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2008, 51 (04) : A76 - A76
  • [45] RELATIONSHIP BETWEEN HYPERURICEMIA AND CHRONIC KIDNEY DISEASE
    Ohno, Iwao
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2011, 30 (12): : 1039 - 1044
  • [46] The grey zone of Hyperuricemia in chronic kidney disease
    Dousdampanis, Periklis
    JOURNAL OF ADVANCED RESEARCH, 2017, 8 (05) : 549 - 550
  • [47] Hyperuricemia and chronic kidney disease: to treat or not to treat
    Piani, Federica
    Sasai, Fumihiko
    Bjornstad, Petter
    Borghi, Claudio
    Yoshimura, Ashio
    Sanchez-Lozada, Laura G.
    Roncal-Jimenez, Carlos
    Garcia, Gabriela E.
    Hernando, Ana Andres
    Fuentes, Gabriel Cara
    Rodriguez-Iturbe, Bernardo
    Lanaspa, Miguel A.
    Johnson, Richard J.
    JORNAL BRASILEIRO DE NEFROLOGIA, 2021, 43 (04): : 572 - 579
  • [48] Effect of hyperuricemia treatment on chronic kidney disease
    Tomoyuki Kawada
    Clinical Rheumatology, 2021, 40 : 4781 - 4781
  • [49] Effect of hyperuricemia treatment on chronic kidney disease
    Kawada, Tomoyuki
    CLINICAL RHEUMATOLOGY, 2021, 40 (11) : 4781 - 4781
  • [50] Joint association of hyperuricemia and chronic kidney disease with mortality in patients with chronic heart failure
    Wang, Chi
    Che, Hebin
    Zhou, You
    Wang, Ruiqing
    Zhu, Di
    Cheng, Liting
    Rao, Chongyou
    Zhong, Qin
    Li, Zongren
    Duan, Yongjie
    Xu, Jiayu
    Dong, Wei
    Bai, Yongyi
    He, Kunlun
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
12345